Rocket Pharmaceuticals (RCKT) News Today → The Best AI Stock to Own in the World Today is Trading for Just $25 (From Banyan Hill Publishing) (Ad) Free RCKT Stock Alerts $23.40 -0.26 (-1.10%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11, 2024 | americanbankingnews.comRocket Pharmaceuticals, Inc. Expected to Earn Q2 2024 Earnings of ($0.69) Per Share (NASDAQ:RCKT)May 10, 2024 | marketbeat.comQ2 2024 EPS Estimates for Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Decreased by Leerink PartnrsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Leerink Partnrs reduced their Q2 2024 earnings per share estimates for Rocket Pharmaceuticals in a research note issued on Tuesday, May 7th. Leerink Partnrs analyst M. Foroohar now expects that the biotechnology company will post earningsMay 10, 2024 | businesswire.comRocket Pharmaceuticals Presents Positive Data from LV Hematology Portfolio at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)May 9, 2024 | americanbankingnews.comEquities Analysts Issue Forecasts for Rocket Pharmaceuticals, Inc.'s Q2 2024 Earnings (NASDAQ:RCKT)May 9, 2024 | americanbankingnews.comRocket Pharmaceuticals (NASDAQ:RCKT) Stock Rating Reaffirmed by Needham & Company LLCMay 8, 2024 | marketwatch.comLockheed Martin Gets $861.3M U.S. Army Rocket-System PactMay 8, 2024 | usnews.comIsrael Reopens Key Crossing for Aid to Enter Gaza That Was Closed Over Weekend Rocket AttackMay 8, 2024 | markets.businessinsider.comOptimistic Outlook for Rocket Pharmaceuticals with Advancing Pipeline and Solid FinancialsMay 7, 2024 | msn.comRocket Knight Adventures: Re-Sparked Collection - Official Pre-Order TrailerMay 7, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Releases Earnings Results, Beats Estimates By $0.01 EPSRocket Pharmaceuticals (NASDAQ:RCKT - Get Free Report) posted its earnings results on Monday. The biotechnology company reported ($0.66) earnings per share for the quarter, topping analysts' consensus estimates of ($0.67) by $0.01. During the same period in the previous year, the company posted ($0.73) EPS.May 7, 2024 | marketbeat.comNeedham & Company LLC Reaffirms Buy Rating for Rocket Pharmaceuticals (NASDAQ:RCKT)Needham & Company LLC restated a "buy" rating and issued a $53.00 target price on shares of Rocket Pharmaceuticals in a research note on Tuesday.May 6, 2024 | investorplace.comRCKT Stock Earnings: Rocket Pharmaceuticals Beats EPS for Q1 2024May 6, 2024 | msn.comRocket Pharmaceuticals GAAP EPS of -$0.66 beats by $0.01May 6, 2024 | msn.comRickie Fowler returning for 2024 Rocket Mortgage Classic in Detroit, tickets on sale nowMay 6, 2024 | businesswire.comRocket Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent ProgressMay 4, 2024 | msn.com3,000+ show up for Cleveland Cavaliers’ watch party at Rocket Mortgage FieldHouse (photos)May 3, 2024 | marketbeat.comRussell Investments Group Ltd. Has $19.45 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Russell Investments Group Ltd. decreased its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 10.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 648,946 shares of the bioMay 2, 2024 | yahoo.comNASA selects Rocket Lab for back-to-back climate change research launchesMay 2, 2024 | msn.comRKT Stock Earnings: Rocket Companies Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | msn.comLouis Leterrier To Direct Sci-Fi Horror Pic ‘11817’; Rocket Science, CAA Launching Sales At CannesMay 1, 2024 | msn.comFortnite Update v29.40 Brings Star Wars to Battle Royale, Lego Fortnite, Fortnite Festival, and Rocket RacingApril 30, 2024 | sports.yahoo.comLions DE Aidan Hutchinson and his family talk Rocket Mortgage and reminisce the NFL DraftApril 30, 2024 | markets.businessinsider.comRocket Pharmaceuticals Upgraded to Buy: Here's WhyApril 29, 2024 | msn.comAs Helldivers 2 players pick the new Airburst Rocket Launcher from the latest Major Order, Super Earth sends potatoes to remember the lostApril 27, 2024 | nasdaq.comFirst Week of June 21st Options Trading For Rocket Pharmaceuticals (RCKT)April 27, 2024 | finance.yahoo.comRocket Pharmaceuticals, Inc. (RCKT)April 26, 2024 | msn.comJapan Announces Plans to Launch Upgraded Observation Satellites on New Flagship Rocket's 3rd FlightApril 26, 2024 | msn.comRocket League and X-Men ’97 Crossover Event Now LiveApril 25, 2024 | insidertrades.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Insider John Militello Sells 833 SharesApril 23, 2024 | msn.comU.S. Space & Rocket Center launches eclipse glasses donation drive for South American childrenApril 23, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Recommendation of "Moderate Buy" by BrokeragesShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have received an average rating of "Moderate Buy" from the nine analysts that are currently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a hold rating and eight have given a buyApril 22, 2024 | msn.comNorth Korean Leader Kim Leads Rocket Drills That Simulate a Nuclear Counterattack Against EnemiesApril 21, 2024 | marketbeat.comVontobel Holding Ltd. Purchases New Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Vontobel Holding Ltd. bought a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 43,540 shares of theApril 19, 2024 | msn.comRocket Run raises money for Gardendale Elementary SchoolApril 19, 2024 | msn.comRonnie O’Sullivan rivals question the Rocket’s World Championship favourite tagApril 18, 2024 | investing.comRocket Pharmaceuticals executive sells over $1.9m in stockApril 18, 2024 | insidertrades.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Director David P. Southwell Sells 10,000 SharesApril 17, 2024 | msn.comInjured South Carolina tailback Rocket Sanders has a timetable in mind for returnApril 17, 2024 | msn.comBrevard political consultant, Space Coast Rocket owner, arrested for alleged PPP loan fraudApril 16, 2024 | marketbeat.comMirae Asset Global Investments Co. Ltd. Decreases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Mirae Asset Global Investments Co. Ltd. lowered its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 55.5% during the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 172,474 shares of the biotechnology company's stock afterApril 13, 2024 | techcrunch.comSpace Force tees up new ‘responsive space’ mission from Rocket Lab and True AnomalyApril 12, 2024 | msn.comBeloved Durant Rocket Park slide staying after allApril 12, 2024 | insidertrades.comMark Andrew White Sells 12,532 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) StockApril 12, 2024 | msn.comRocket League Sideswipe Codes For April 2024April 11, 2024 | yahoo.comSpace Force tees up new 'responsive space' mission from Rocket Lab and True AnomalyApril 11, 2024 | msn.comDurant Rocket Park, Multi-Sports Complex to begin renovationsApril 10, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Insider Sells $308,788.48 in StockRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) insider Mark Andrew White sold 12,532 shares of the company's stock in a transaction on Monday, April 8th. The stock was sold at an average price of $24.64, for a total transaction of $308,788.48. Following the completion of the transaction, the insider now directly owns 75,226 shares in the company, valued at approximately $1,853,568.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.April 10, 2024 | usnews.comRussia Aborts Angara-A5 Space Rocket Launch for Second TimeApril 10, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Earns "Buy" Rating from Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and issued a $53.00 price target on shares of Rocket Pharmaceuticals in a research report on Wednesday.April 5, 2024 | msn.comSyracuse Crunch rally past Laval Rocket, 3-1 Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address A ‘DeFi Summer’ Projected! (Ad)Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x! Just click here to learn how you can access this coin right now. RCKT Media Mentions By Week RCKT Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼0.340.55▲Average Medical News Sentiment RCKT News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼98▲RCKT Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: ZLAB News Today AMRX News Today DCPH News Today ARVN News Today GERN News Today VERA News Today AMPH News Today EVO News Today CPRX News Today AGIO News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportBiden to Drop BOMBSHELL June 13th?Paradigm PressElon to Transform U.S. Economy? Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityThe most important AI company you've never heard ofManward PressThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyElon’s New Device is About to Shock the WorldInvestorPlaceGold ManiaStansberry Research Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
